Cargando…

Ovarian reserve in women with sickle cell disease

BACKGROUND: It has been proposed that ovarian sickling and/or iron overload in women with sickle cell disease (SCD) could contribute to gonadal dysfunction, but there are very few published studies. We hypothesised that the above phenomena might impair ovarian reserve. METHODS: A total of 50 SCD pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopeika, Julia, Oyewo, Adeola, Punnialingam, Sinthiya, Reddy, Nivedita, Khalaf, Yacoub, Howard, Jo, Mononen, Sofia, Oteng-Ntim, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386479/
https://www.ncbi.nlm.nih.gov/pubmed/30794713
http://dx.doi.org/10.1371/journal.pone.0213024
_version_ 1783397388972457984
author Kopeika, Julia
Oyewo, Adeola
Punnialingam, Sinthiya
Reddy, Nivedita
Khalaf, Yacoub
Howard, Jo
Mononen, Sofia
Oteng-Ntim, Eugene
author_facet Kopeika, Julia
Oyewo, Adeola
Punnialingam, Sinthiya
Reddy, Nivedita
Khalaf, Yacoub
Howard, Jo
Mononen, Sofia
Oteng-Ntim, Eugene
author_sort Kopeika, Julia
collection PubMed
description BACKGROUND: It has been proposed that ovarian sickling and/or iron overload in women with sickle cell disease (SCD) could contribute to gonadal dysfunction, but there are very few published studies. We hypothesised that the above phenomena might impair ovarian reserve. METHODS: A total of 50 SCD patients were case-matched by age, ethnicity, and presence of regular cycles (28±5 days) with 73 patients without a known haemoglobinopathy who required anti-Müllerian hormone (AMH) assessment in a gynaecology clinic. SCD patients had AMH levels taken as part of routine care. The patients were case-controlled and matched with patients who had no haemoglobinopathy in a tertiary centre over a period of one year. RESULTS: The mean AMH in the SCD case group was 7.6 pmol/l compared with 13.4 pmol/l in the control group (p<0.001). The AMH distributions were subsequently categorised. This showed that SCD patients had a significantly higher chance of having lower AMH in comparison with the control group (OR 2.6 (CI 1.1–6.5, P = 0.02). The proportion of women with AMH > 20 pmol/l was significantly lower in the SCD group (6%) in comparison with the control group (19%) (P = 0.04). CONCLUSIONS: This is the first study showing that women of reproductive age with SCD are more likely to have a low ovarian reserve at a younger age in comparison with patients with no haemoglobinopathy.
format Online
Article
Text
id pubmed-6386479
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63864792019-03-09 Ovarian reserve in women with sickle cell disease Kopeika, Julia Oyewo, Adeola Punnialingam, Sinthiya Reddy, Nivedita Khalaf, Yacoub Howard, Jo Mononen, Sofia Oteng-Ntim, Eugene PLoS One Research Article BACKGROUND: It has been proposed that ovarian sickling and/or iron overload in women with sickle cell disease (SCD) could contribute to gonadal dysfunction, but there are very few published studies. We hypothesised that the above phenomena might impair ovarian reserve. METHODS: A total of 50 SCD patients were case-matched by age, ethnicity, and presence of regular cycles (28±5 days) with 73 patients without a known haemoglobinopathy who required anti-Müllerian hormone (AMH) assessment in a gynaecology clinic. SCD patients had AMH levels taken as part of routine care. The patients were case-controlled and matched with patients who had no haemoglobinopathy in a tertiary centre over a period of one year. RESULTS: The mean AMH in the SCD case group was 7.6 pmol/l compared with 13.4 pmol/l in the control group (p<0.001). The AMH distributions were subsequently categorised. This showed that SCD patients had a significantly higher chance of having lower AMH in comparison with the control group (OR 2.6 (CI 1.1–6.5, P = 0.02). The proportion of women with AMH > 20 pmol/l was significantly lower in the SCD group (6%) in comparison with the control group (19%) (P = 0.04). CONCLUSIONS: This is the first study showing that women of reproductive age with SCD are more likely to have a low ovarian reserve at a younger age in comparison with patients with no haemoglobinopathy. Public Library of Science 2019-02-22 /pmc/articles/PMC6386479/ /pubmed/30794713 http://dx.doi.org/10.1371/journal.pone.0213024 Text en © 2019 Kopeika et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kopeika, Julia
Oyewo, Adeola
Punnialingam, Sinthiya
Reddy, Nivedita
Khalaf, Yacoub
Howard, Jo
Mononen, Sofia
Oteng-Ntim, Eugene
Ovarian reserve in women with sickle cell disease
title Ovarian reserve in women with sickle cell disease
title_full Ovarian reserve in women with sickle cell disease
title_fullStr Ovarian reserve in women with sickle cell disease
title_full_unstemmed Ovarian reserve in women with sickle cell disease
title_short Ovarian reserve in women with sickle cell disease
title_sort ovarian reserve in women with sickle cell disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386479/
https://www.ncbi.nlm.nih.gov/pubmed/30794713
http://dx.doi.org/10.1371/journal.pone.0213024
work_keys_str_mv AT kopeikajulia ovarianreserveinwomenwithsicklecelldisease
AT oyewoadeola ovarianreserveinwomenwithsicklecelldisease
AT punnialingamsinthiya ovarianreserveinwomenwithsicklecelldisease
AT reddynivedita ovarianreserveinwomenwithsicklecelldisease
AT khalafyacoub ovarianreserveinwomenwithsicklecelldisease
AT howardjo ovarianreserveinwomenwithsicklecelldisease
AT mononensofia ovarianreserveinwomenwithsicklecelldisease
AT otengntimeugene ovarianreserveinwomenwithsicklecelldisease